This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Sanofi Pasteur Inc., Sanofi Pasteur Sa. Active years: 2016-2022.
Company Filing History:
Years Active: 2016-2022
Title: The Innovations of Pascal Chaux
Introduction
Pascal Chaux is a notable inventor based in Bully, France. He has made significant contributions to the field of immunology, particularly in the development of vaccines against human cytomegalovirus (HCMV). With a total of 3 patents to his name, Chaux's work is recognized for its potential impact on public health.
Latest Patents
Chaux's latest patents focus on immunogenic compositions for HCMV. One of his inventions relates to an immunogenic composition comprising an HCMV gB antigen, an HCMV gH/gL/UL128/UL130/UL131 pentameric complex antigen, and a Th1-inducing adjuvant. This composition is designed for use as an HCMV vaccine. Another patent also centers on an immunogenic composition that includes the HCMV gH/gL/UL128/UL130/UL131 pentameric complex antigen and a TH1-inducing adjuvant, further emphasizing its application as a vaccine against HCMV.
Career Highlights
Throughout his career, Pascal Chaux has worked with prominent companies in the pharmaceutical industry, including Sanofi Pasteur Inc. and Sanofi Pasteur SA. His experience in these organizations has contributed to his expertise in vaccine development and immunology.
Collaborations
Chaux has collaborated with several professionals in his field, including Jean Haensler and Rafaela Dumas. These partnerships have likely enhanced his research and innovation efforts.
Conclusion
Pascal Chaux's contributions to the field of immunology, particularly through his patents related to HCMV vaccines, highlight his role as an influential inventor. His work continues to pave the way for advancements in vaccine development and public health.